Yeboah Joseph, Folsom Aaron R, Burke Gregory L, Johnson Craig, Polak Joseph F, Post Wendy, Lima Joao A, Crouse John R, Herrington David M
Department of Internal Medicine/Cardiology, University of Virginia Medical Center, Charlottesville, VA 22908, USA.
Circulation. 2009 Aug 11;120(6):502-9. doi: 10.1161/CIRCULATIONAHA.109.864801. Epub 2009 Jul 27.
Although brachial artery flow-mediated dilation (FMD) predicts recurrent cardiovascular events, its predictive value for incident cardiovascular disease (CVD) events in adults free of CVD is not well established. We assessed the predictive value of FMD for incident CVD events in the Multi-Ethnic Study of Atherosclerosis (MESA).
Brachial artery FMD was measured in a nested case-cohort sample of 3026 of 6814 subjects (mean+/-SD age, 61.2+/-9.9 years) in MESA, a population-based cohort study of adults free of clinical CVD at baseline recruited at 6 clinic sites in the United States. The sample included 50.2% female, 34.3% white, 19.7% Chinese, 20.8% black, and 25.1% Hispanic subjects. Probability-weighted Cox proportional hazards analysis was used to examine the association between FMD and 5 years of adjudicated incident CVD events, including incident myocardial infarction, definite angina, coronary revascularization (coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, or other revascularization), stroke, resuscitated cardiac arrest, and CVD death. Mean (SD) FMD of the cohort was 4.4% (2.8). In probability-weighted Cox models, FMD/unit SD was significantly associated with incident cardiovascular events in the univariate model (adjusted for age and sex) (hazard ratio, 0.79; 95% confidence interval, 0.65 to 0.97; P=0.01), after adjustment for the Framingham Risk Score (FRS) (hazard ratio, 0.80; 95% confidence interval, 0.62 to 0.97; P=0.025), and in the multivariable model (hazard ratio, 0.84; 95% confidence interval, 0.71 to 0.99; P=0.04) after adjustment for age, sex, diabetes mellitus, cigarette smoking status, systolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, heart rate, statin use, and blood pressure medication use. The c statistic (area under the curve) values of FMD, FRS, and FRS+FMD were 0.65, 0.74, and 0.74, respectively. Compared with the FRS alone, the addition of FMD to the FRS net correctly reclassifies 52% of subjects with no incident CVD event but net incorrectly reclassifies 23% of subjects with an incident CVD event, an overall net correct reclassification of 29% (P<0.001).
Brachial FMD is a predictor of incident cardiovascular events in population-based adults. Even though the addition of FMD to the FRS did not improve discrimination of subjects at risk of CVD events in receiver operating characteristic analysis, it improved the classification of subjects as low, intermediate, and high CVD risk compared with the FRS.
尽管肱动脉血流介导的血管舒张功能(FMD)可预测心血管事件复发,但其对无心血管疾病(CVD)的成年人发生心血管疾病(CVD)事件的预测价值尚未明确。我们在动脉粥样硬化多民族研究(MESA)中评估了FMD对发生CVD事件的预测价值。
在MESA研究中,对6814名受试者中的3026名(平均±标准差年龄为61.2±9.9岁)进行了肱动脉FMD测量,该研究是一项基于人群的队列研究,基线时无临床CVD的成年人在美国6个临床地点招募。样本包括50.2%的女性、34.3%的白人、19.7%的中国人、20.8%的黑人以及25.1%的西班牙裔受试者。采用概率加权Cox比例风险分析来检验FMD与5年判定的CVD事件之间的关联,这些事件包括心肌梗死、确诊心绞痛、冠状动脉血运重建(冠状动脉搭桥术、经皮冠状动脉腔内血管成形术或其他血运重建)、中风、复苏的心脏骤停以及CVD死亡。队列的平均(标准差)FMD为4.4%(2.8)。在概率加权Cox模型中,在单变量模型(调整年龄和性别)中,FMD/单位标准差与发生心血管事件显著相关(风险比,0.79;95%置信区间,0.65至0.97;P = 0.01),在调整弗明汉风险评分(FRS)后(风险比,0.80;95%置信区间,0.62至0.97;P = 0.025),以及在多变量模型中(风险比,0.84;95%置信区间,0.71至0.99;P = 0.04),该模型调整了年龄、性别、糖尿病、吸烟状况、收缩压、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、甘油三酯、心率、他汀类药物使用和血压药物使用情况。FMD、FRS以及FRS + FMD的c统计量(曲线下面积)值分别为0.65、0.74和0.74。与单独使用FRS相比,将FMD添加到FRS中能正确重新分类52%无CVD事件发生的受试者,但错误地重新分类了23%有CVD事件发生的受试者,总体净正确重新分类率为29%(P < 0.001)。
肱动脉FMD是基于人群的成年人发生心血管事件的预测指标。尽管在接受者操作特征分析中,将FMD添加到FRS中并未改善对有CVD事件风险受试者的鉴别能力,但与FRS相比,它改善了对受试者低、中、高CVD风险的分类。